Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
polymyxin b + trimethoprim + carboxymethyl cellulose
- Development stage
- Unknown
- Modality
- Small Molecules
- Administration
- Ophthalmic
01
Overview
A combination ophthalmic solution containing polymyxin B (an antibiotic that breaks bacterial cell membranes), trimethoprim (an antifolate that inhibits bacterial dihydrofolate reductase), and carboxymethyl cellulose (likely serving as a lubricant or viscosity-enhancing agent). This combination would be used to treat bacterial eye infections while providing additional lubrication for patient comfort.
02
Targets
DHFR (Dihydrofolate reductase)GLUT1 (Glucose transporter 1)
Beyond the preview
Go deeper on polymyxin b + trimethoprim + carboxymethyl cellulose.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on polymyxin b + trimethoprim + carboxymethyl cellulose.